Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chair & CEO, Director
-
Stock Symbol
-
ZYME on Nasdaq
Kenneth Galbraith - trading volume in the past year for Zymeworks Inc.
Holdings reported by Kenneth Galbraith for Zymeworks Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Restricted Stock Unit |
200K |
$2.24M |
$11.22 |
Jan 5, 2024 |
Direct |
Common Stock |
|
| Restricted Stock Unit |
133K |
$1.99M |
$14.92 |
Jan 6, 2025 |
Direct |
Common Stock |
|
| Common Stock |
80.8K |
$1.21M |
$14.92 |
Jan 6, 2025 |
Direct |
|
|
| Stock Option (Right to Buy) |
300K |
|
|
Jan 5, 2024 |
Direct |
Common Stock |
|
Transactions reported by Kenneth Galbraith for Zymeworks Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.